+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hand-held Glucose Meter Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 260 Pages
  • October 2024
  • Region: Global
  • Allied Market Research
  • ID: 6053895
Description Jump to:
The hand-held glucose meter market was valued at $1.2 billion in 2023, and is projected to reach $2.0 billion by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

A hand-held glucose meter is a compact, portable medical device designed to measure and monitor blood glucose levels. It serves as an essential tool for individuals with diabetes, allowing them to track their blood sugar levels accurately and conveniently from home or on the go. The device works by analyzing a small drop of blood, usually obtained through a finger prick, which is placed on a disposable test strip. The glucose meter then provides a digital readout of the blood glucose concentration within seconds.

The growth of the global hand-held glucose meter market is driven by alarming rise in prevalence of diabetes and surge in demand for reliable glucose monitoring devices. The IDF Diabetes Atlas (2021) reports that approximately 540 million individuals were suffering from diabetes worldwide. This number is estimated to rise to 643 million by 2030 and 783 million by 2045. In addition, increase in awareness of self-monitoring for diabetes management has fostered the demand for user-friendly and accurate handheld glucose meters, thus strengthening the market growth. Furthermore, surge in geriatric population significantly contributes toward the growth of the global market.

This is attributed to the fact that as people age, their bodies experience a natural decline in insulin production and sensitivity, leading to higher blood glucose levels and an increased risk of developing type 2 diabetes. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Moreover, shift toward preventive healthcare that encourages more people to monitor their health conditions regularly augments the adoption of personal glucose meters. However, accuracy and calibration concerns associated with hand-held glucose meters hamper the market growth.

In addition, lack of diabetes education and economic constraints act as the key deterrent factors of the global market. On the contrary, continuous improvements in sensor technology, data connectivity, and digital health integration have made glucose meters more accurate, easier to use, and compatible with health apps, enhancing their appeal and usability. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The global hand-held glucose meter industry is segmented into product, end user, and region. On the basis of product, the market is classified into standard glucose meters, smart glucose meters, and continuous glucose monitors. Depending on end user, it is divided into hospitals & clinics, homecare, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the smart glucose meters segment is expected to dominated the market from 2024 to 2033.

Depending on end user, the hospitals & clinics segment is anticipated to exhibit the highest growth during the forecast period.

By region, North America held the largest market share in terms of revenue in 2023, and is projected to dominate the market throughout the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global hand-held glucose meter market include F. Hoffmann La Roche, Abbott Laboratories, Johnson & Johnson Company, DexCom, Inc., Medtronic Plc, Bayer AG, Ascensia Diabetes Care Holdings AG, Terumo Corporation, Nova Biomedical Corporation, and Ypsomed Holding AG. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Product

  • Standard Glucose Meters
  • Smart Glucose Meters
  • Continuous Glucose Monitors

By End User

  • Hospitals and Clinics
  • Homecare
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • F. Hoffmann La Roche
  • Abbott Laboratories
  • Johnson & Johnson Company
  • DexCom, Inc.
  • Medtronic plc
  • Bayer AG
  • Ascensia Diabetes Care Holdings AG
  • Terumo Corporation
  • Nova Biomedical Corporation
  • Ypsomed Holding AG

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: HAND-HELD GLUCOSE METER MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Standard Glucose Meters
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Smart Glucose Meters
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Continuous Glucose Monitors
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: HAND-HELD GLUCOSE METER MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals And Clinics
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Homecare
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: HAND-HELD GLUCOSE METER MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Hand-held Glucose Meter Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Hand-held Glucose Meter Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Hand-held Glucose Meter Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. France Hand-held Glucose Meter Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End User
6.3.6. Germany Hand-held Glucose Meter Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End User
6.3.7. Italy Hand-held Glucose Meter Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Spain Hand-held Glucose Meter Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End User
6.3.9. UK Hand-held Glucose Meter Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Hand-held Glucose Meter Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. China Hand-held Glucose Meter Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End User
6.4.6. Japan Hand-held Glucose Meter Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Hand-held Glucose Meter Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Hand-held Glucose Meter Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Hand-held Glucose Meter Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Hand-held Glucose Meter Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Hand-held Glucose Meter Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End User
6.5.6. South Africa Hand-held Glucose Meter Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End User
6.5.7. Saudi Arabia Hand-held Glucose Meter Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Hand-held Glucose Meter Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. F. Hoffmann La Roche
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Abbott Laboratories
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Johnson And Johnson Company
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. DexCom, Inc.
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Medtronic Plc
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Bayer AG
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Ascensia Diabetes Care Holdings AG
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Terumo Corporation
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Nova Biomedical Corporation
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Ypsomed Holding AG
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 2. Hand-Held Glucose Meter Market for Standard Glucose Meters, by Region, 2024 - 2033 ($Billion)
Table 3. Hand-Held Glucose Meter Market for Smart Glucose Meters, by Region, 2024 - 2033 ($Billion)
Table 4. Hand-Held Glucose Meter Market for Continuous Glucose Monitors, by Region, 2024 - 2033 ($Billion)
Table 5. Global Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 6. Hand-Held Glucose Meter Market for Hospitals and Clinics, by Region, 2024 - 2033 ($Billion)
Table 7. Hand-Held Glucose Meter Market for Homecare, by Region, 2024 - 2033 ($Billion)
Table 8. Hand-Held Glucose Meter Market for Others, by Region, 2024 - 2033 ($Billion)
Table 9. Hand-Held Glucose Meter Market, by Region, 2024 - 2033 ($Billion)
Table 10. North America Hand-Held Glucose Meter Market, by Country, 2024 - 2033 ($Billion)
Table 11. North America Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 12. North America Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 13. U.S. Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 14. U.S. Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 15. Canada Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 16. Canada Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 17. Mexico Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 18. Mexico Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 19. Europe Hand-Held Glucose Meter Market, by Country, 2024 - 2033 ($Billion)
Table 20. Europe Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 21. Europe Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 22. France Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 23. France Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 24. Germany Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 25. Germany Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 26. Italy Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 27. Italy Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 28. Spain Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 29. Spain Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 30. UK Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 31. UK Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 32. Rest of Europe Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 33. Rest of Europe Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 34. Asia-Pacific Hand-Held Glucose Meter Market, by Country, 2024 - 2033 ($Billion)
Table 35. Asia-Pacific Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 36. Asia-Pacific Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 37. China Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 38. China Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 39. Japan Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 40. Japan Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 41. India Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 42. India Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 43. South Korea Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 44. South Korea Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 45. Australia Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 46. Australia Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 47. Rest of Asia-Pacific Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 48. Rest of Asia-Pacific Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 49. LAMEA Hand-Held Glucose Meter Market, by Country, 2024 - 2033 ($Billion)
Table 50. LAMEA Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 51. LAMEA Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 52. Brazil Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 53. Brazil Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 54. South Africa Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 55. South Africa Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 56. Saudi Arabia Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 57. Saudi Arabia Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 58. Rest of LAMEA Hand-Held Glucose Meter Market, by Product, 2024 - 2033 ($Billion)
Table 59. Rest of LAMEA Hand-Held Glucose Meter Market, by End-user, 2024 - 2033 ($Billion)
Table 60. F. Hoffmann La Roche: Key Executives
Table 61. F. Hoffmann La Roche: Company Snapshot
Table 62. F. Hoffmann La Roche: Operating Segments
Table 63. F. Hoffmann La Roche: Product Portfolio
Table 64. F. Hoffmann La Roche: Key Strategic Moves and Developments
Table 65. Abbott Laboratories: Key Executives
Table 66. Abbott Laboratories: Company Snapshot
Table 67. Abbott Laboratories: Operating Segments
Table 68. Abbott Laboratories: Product Portfolio
Table 69. Abbott Laboratories: Key Strategic Moves and Developments
Table 70. Johnson and Johnson Company: Key Executives
Table 71. Johnson and Johnson Company: Company Snapshot
Table 72. Johnson and Johnson Company: Operating Segments
Table 73. Johnson and Johnson Company: Product Portfolio
Table 74. Johnson and Johnson Company: Key Strategic Moves and Developments
Table 75. Dexcom, Inc.: Key Executives
Table 76. Dexcom, Inc.: Company Snapshot
Table 77. Dexcom, Inc.: Operating Segments
Table 78. Dexcom, Inc.: Product Portfolio
Table 79. Dexcom, Inc.: Key Strategic Moves and Developments
Table 80. Medtronic PLC: Key Executives
Table 81. Medtronic PLC: Company Snapshot
Table 82. Medtronic PLC: Operating Segments
Table 83. Medtronic PLC: Product Portfolio
Table 84. Medtronic PLC: Key Strategic Moves and Developments
Table 85. Bayer AG: Key Executives
Table 86. Bayer AG: Company Snapshot
Table 87. Bayer AG: Operating Segments
Table 88. Bayer AG: Product Portfolio
Table 89. Bayer AG: Key Strategic Moves and Developments
Table 90. Ascensia Diabetes Care Holdings AG: Key Executives
Table 91. Ascensia Diabetes Care Holdings AG: Company Snapshot
Table 92. Ascensia Diabetes Care Holdings AG: Operating Segments
Table 93. Ascensia Diabetes Care Holdings AG: Product Portfolio
Table 94. Ascensia Diabetes Care Holdings AG: Key Strategic Moves and Developments
Table 95. Terumo Corporation: Key Executives
Table 96. Terumo Corporation: Company Snapshot
Table 97. Terumo Corporation: Operating Segments
Table 98. Terumo Corporation: Product Portfolio
Table 99. Terumo Corporation: Key Strategic Moves and Developments
Table 100. Nova Biomedical Corporation: Key Executives
Table 101. Nova Biomedical Corporation: Company Snapshot
Table 102. Nova Biomedical Corporation: Operating Segments
Table 103. Nova Biomedical Corporation: Product Portfolio
Table 104. Nova Biomedical Corporation: Key Strategic Moves and Developments
Table 105. Ypsomed Holding AG: Key Executives
Table 106. Ypsomed Holding AG: Company Snapshot
Table 107. Ypsomed Holding AG: Operating Segments
Table 108. Ypsomed Holding AG: Product Portfolio
Table 109. Ypsomed Holding AG: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Hand-Held Glucose Meter Market, 2024 - 2033
Figure 2. Segmentation of Hand-Held Glucose Meter Market, 2024 - 2033
Figure 3. Top Investment Pocket in Hand-Held Glucose Meter Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalhand-Held Glucose Meter Market
Figure 10. Global Hand-Held Glucose Meter Market Segmentation, by Product
Figure 11. Hand-Held Glucose Meter Market for Standard Glucose Meters, by Country, 2024 - 2033 ($Billion)
Figure 12. Hand-Held Glucose Meter Market for Smart Glucose Meters, by Country, 2024 - 2033 ($Billion)
Figure 13. Hand-Held Glucose Meter Market for Continuous Glucose Monitors, by Country, 2024 - 2033 ($Billion)
Figure 14. Global Hand-Held Glucose Meter Market Segmentation, by End-user
Figure 15. Hand-Held Glucose Meter Market for Hospitals and Clinics, by Country, 2024 - 2033 ($Billion)
Figure 16. Hand-Held Glucose Meter Market for Homecare, by Country, 2024 - 2033 ($Billion)
Figure 17. Hand-Held Glucose Meter Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 18. Top Winning Strategies, by Year, 2021-2023*
Figure 19. Top Winning Strategies, by Development, 2021-2023*
Figure 20. Top Winning Strategies, by Company, 2021-2023*
Figure 21. Product Mapping of Top 10 Players
Figure 22. Competitive Dashboard
Figure 23. Competitive Heatmap: Hand-Held Glucose Meter Market
Figure 24. Top Player Positioning, 2023
Figure 25. F. Hoffmann La Roche: Net Sales, 2021-2023 ($Billion)
Figure 26. F. Hoffmann La Roche: Revenue Share, by Segment, 2023 (%)
Figure 27. F. Hoffmann La Roche: Revenue Share, by Region, 2023 (%)
Figure 28. Abbott Laboratories: Net Sales, 2021-2023 ($Billion)
Figure 29. Abbott Laboratories: Revenue Share, by Segment, 2023 (%)
Figure 30. Abbott Laboratories: Revenue Share, by Region, 2023 (%)
Figure 31. Johnson and Johnson Company: Net Sales, 2021-2023 ($Billion)
Figure 32. Johnson and Johnson Company: Revenue Share, by Segment, 2023 (%)
Figure 33. Johnson and Johnson Company: Revenue Share, by Region, 2023 (%)
Figure 34. Dexcom, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 35. Dexcom, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 36. Dexcom, Inc.: Revenue Share, by Region, 2023 (%)
Figure 37. Medtronic PLC: Net Sales, 2021-2023 ($Billion)
Figure 38. Medtronic PLC: Revenue Share, by Segment, 2023 (%)
Figure 39. Medtronic PLC: Revenue Share, by Region, 2023 (%)
Figure 40. Bayer AG: Net Sales, 2021-2023 ($Billion)
Figure 41. Bayer AG: Revenue Share, by Segment, 2023 (%)
Figure 42. Bayer AG: Revenue Share, by Region, 2023 (%)
Figure 43. Ascensia Diabetes Care Holdings AG: Net Sales, 2021-2023 ($Billion)
Figure 44. Ascensia Diabetes Care Holdings AG: Revenue Share, by Segment, 2023 (%)
Figure 45. Ascensia Diabetes Care Holdings AG: Revenue Share, by Region, 2023 (%)
Figure 46. Terumo Corporation: Net Sales, 2021-2023 ($Billion)
Figure 47. Terumo Corporation: Revenue Share, by Segment, 2023 (%)
Figure 48. Terumo Corporation: Revenue Share, by Region, 2023 (%)
Figure 49. Nova Biomedical Corporation: Net Sales, 2021-2023 ($Billion)
Figure 50. Nova Biomedical Corporation: Revenue Share, by Segment, 2023 (%)
Figure 51. Nova Biomedical Corporation: Revenue Share, by Region, 2023 (%)
Figure 52. Ypsomed Holding AG: Net Sales, 2021-2023 ($Billion)
Figure 53. Ypsomed Holding AG: Revenue Share, by Segment, 2023 (%)
Figure 54. Ypsomed Holding AG: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • F. Hoffmann La Roche
  • Abbott Laboratories
  • Johnson & Johnson Company
  • DexCom, Inc.
  • Medtronic plc
  • Bayer AG
  • Ascensia Diabetes Care Holdings AG
  • Terumo Corporation
  • Nova Biomedical Corporation
  • Ypsomed Holding AG

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages260
PublishedOctober 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 1.2 billion
Forecasted Market Value ( USD ) by 2033 $ 2 billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Glucose Meter Market: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Image

Glucose Meter Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • 216 Pages
  • Global
From
Blood Glucose Meters Market Report 2025 - Product Image

Blood Glucose Meters Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Glucose Monitoring Devices Market By Device: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Image

Glucose Monitoring Devices Market By Device: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • 216 Pages
  • Global
From
Self-Monitoring Blood Glucose Device Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Self-Monitoring Blood Glucose Device Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Blood Glucose Meters - Global Strategic Business Report - Product Image

Blood Glucose Meters - Global Strategic Business Report

  • Report
  • 91 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.